Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.6.1.2 (
alanine aminotransferase
)
26,722
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Plasma B-6 vitamer and plasma and urinary 4-pyridoxic acid concentrations of 21 young white women, 21-27 years, having radiomonitored pyridoxal 5'-phosphate and coenzyme stimulation of erythrocyte
alanine aminotransferase
activities indicative of adequate vitamin B-6 status were determined in an effort to establish normal ranges for plasma B-6 vitamers. B-6 vitamers and 4-pyridoxic acid were quantitated using reversed phase high performance liquid chromatography with fluorometric and ultraviolet detection.
Pyridoxal phosphate
values obtained by radioenzymatic and chromatographic, fluorometric and ultraviolet, assays were highly correlated as were pyridoxine phosphate values determined using both detectors. The B-6 vitamer and 4-pyridoxic acid values of these subjects should be of use in the establishment of normal ranges of these congeners in women.
...
PMID:Plasma B-6 vitamer and plasma and urinary 4-pyridoxic acid concentrations in young women as determined using high performance liquid chromatography. 174 49
Pyridoxal phosphate
(
PLP
) is the coenzyme of
alanine aminotransferase
(
ALT
) and aspartate aminotransferase (AST). Thus, in vitro supplementation with
PLP
is important for the optimisation of the determination of catalytic activity of both enzymes. It patients with kidney transplants, stimulation by
PLP
is very important for
ALT
activity, which could be affected by plasma
PLP
deficiency. Furthermore, in this population catalytic activities are more frequently found increased using methods with
PLP
supplementation than without
PLP
supplementation (56% and 71% of patients for AST and
ALT
, respectively). These differences are not related to HBs antigen.
...
PMID:[In vitro supplementation of pyridoxal phosphate for the optimisation of the determination of the catalytic activity of alanine aminotransferase and aspartate aminotransferase in kidney transplant patients (author's transl)]. 703 70